Hemostasis disorders in the outpatient hematologist practice

Abstract

Summary. Hematologists often consult patients with suspected hemostasis disorders; however, not all these patients require specialized care. The most common reasons for seeking consultation with a hematologist include changes in laboratory tests that lack diagnostic value and a history of thrombotic or obstetric complications. Many of these issues can be addressed without the involvement of a hematologist, particularly when patients with suspected hemostasis disorders receive meticulous attention, their medical histories are thoroughly evalu- ated, and basic laboratory tests are appropriately interpreted. This article presents the author’s perspective, based on personal experience, which may contribute to the optimization of the patient flow from various specialists to hematologists.

For citation: Matvienko O. Yu. Hemostasis disorders in the outpatient hematologist practice. Tromboz, gemostaz i reologiya. 2025;(4):108–114. (In Russ.).

References

1. Momot A.P. Pathology of hemostasis. Principles and algorithms of clinical laboratory diagnostics. Saint Petersburg: FormaT, 2006. 208 pp. (In Russ.).
2. Dobrovolsky A. B., Titaeva E. V. Screening of clotting system disorders by laboratory tests. Rossijskij kardiologicheskij zhurnal. 2015;(3):52–7. (In Russ.). DOI: 10.15829/1560-4071-2015-03-52-57.
3. Barkagan Z.S. Hemostasis. In: Handbook of Hematology. Ed. A.I. Vorobyov. Moscow: N’yudiamed, 2005. 9–147. (In Russ.).
4. Solovieva I.V. D-dimer: clinical significance for elderly patients. Laboratornaya sluzhba. 2017;6(1):14–22. (In Russ.). DOI: 10.17116/ labs20176114-22. (In Russ.).
5. Van Es J., Mos I., Douma R. et al. The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number ofpatients in whom acute pulmonary embolism can safely be excluded. Thromb Haemost. 2012;107(1):167–71. DOI: 10.1160/TH11-08-0587.
6. Seliverstov E.I., Lobastov K.V., Ilyukhin E.A. et al. Prevention, diagnostics and treatment of deep vein thrombosis. Russian experts consensus. Flebologiya. 2023;17(3):152–296. (In Russ.). DOI: 10.17116/ flebo202317031152.
7. Clinical guidelines — Venous complications during pregnancy and the postpartum period. Obstetric thromboembolism — 2022–2023–2024 (14.02.2022). Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2022. 66 pp. (In Russ.). Available at: https://phlebology-sro.ru/upload/iblock/72a/vteo-vo-vremyaberemennosti-i-poslerodovom-periode-2022.pdf. [Accessed: 20.11.2024].
8. Papayan L.P., Kapustin S.I., Shmeleva V.M., Kobilyanskaya V.A. Thrombophilia. Congenital and acquired disorders of hemostasis predisposing to the development of thrombosis. In: Rational pharmacotherapy in hematology. Ed O.A. Rukavitsyn. Moscow: Litterra, 2021. 15–28. (In Russ.).
9. Papayan L.P., Golovina O.G., Matvienko O.Yu., Silina N.N. Hereditary thrombophilia. A textbook. Saint Petersburg: OOO «IPK «Gangut», 2022. 24 pp. (In Russ.).
10. Colucci G., Tsakiris D.A. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis. 2020;49(4):618– 29. DOI: 10.1007/s11239-020-02090-y.
11. Momot A.P. The problem of thrombophilia in clinical practice. Rossijskij zhurnal detskoj gematologii i onkologii. 2015;2(1):36–48. (In Russ.). DOI: 10.17650/2311-1267-2015-1-36-48.
12. Korsakova N.E., Matvienko O. Yu. In: Antiphospholipid syndrome: clinical and laboratory aspects. In: Federal hematology guidelines. Eds. S.S. Bessmeltsev, S.V. Sidorkevich. Moscow: SIMK, 2024. 418– 37. (In Russ.).
13. Reshetnyak T.M. Recommendations for antiphospholipid syndrome treatment. Moscow, 2013. 24 pp. (In Russ.). Available at: https:// mzur.ru/upload/iblock/8f0/AFS.pdf. [Accessed: 20.11.2024].
14. Petri M. Antiphospholipid syndrome. Transl Res. 2020;225:70–81. DOI: 10.1016/j.trsl.2020.04.006.
15. Reshetnyak T.M. Antiphospholipid syndrome: diagnosis and clinical manifestations (a lecture). Nauchno-prakticheskaya revmatologiya. 2014;52(1):56–71. (In Russ.). DOI: 10.14412/1995-4484-2014-56-71.
16. Devreese K.M.J., Ortel T.L., Pengo V., de Laat B.; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J Thromb Haemost. 2018;16(4):809–13. DOI: 10.1111/ jth.13976.
17. Mc Caddon A., Miller J.W. Homocysteine — a retrospective and prospective appraisal. Front Nutr. 2023;10:1179807. DOI: 10.3389/ fnut.2023.1179807.